1XWD | F:193-246; F:193-246; F:193-246; F:193-246 | CRYSTAL STRUCTURE OF HUMAN FOLLICLE STIMULATING HORMONE COMPLEXED WITH ITS RECEPTOR |
1M0Z | B:148-197; B:148-197; B:148-197; B:148-197 | CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR BINDING DOMAIN OF GLYCOPROTEIN IB ALPHA |
1M10 | B:148-197; B:148-197 | CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN |
1OOK | G:148-197; G:148-197 | CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN |
1P8V | A:148-197; A:148-197 | CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND ALPHA-THROMBIN AT 2.6A |
1P9A | G:148-197; G:148-197 | CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AT 1.7 ANGSTROM RESOLUTION |
1QYY | G:148-197; G:148-197; G:148-197; G:148-197 | CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AT 2.8 ANGSTROM RESOLUTION |
1SQ0 | B:148-197; B:148-197 | CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION |
1U0N | D:148-197; D:148-197 | THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA-BOTROCETIN COMPLEX |
3P72 | A:148-197; A:148-197 | STRUCTURE OF PLATELET GLYCOPROTEIN 1B ALPHA WITH A BOUND PEPTIDE INHIBITOR |
3PMH | G:148-197; G:148-197 | MECHANISM OF SULFOTYROSINE-MEDIATED GLYCOPROTEIN IB INTERACTION WITH TWO DISTINCT ALPHA-THROMBIN SITES |
1OZN | A:202-261; A:202-261; A:202-261 | 1.5A CRYSTAL STRUCTURE OF THE NOGO RECEPTOR LIGAND BINDING DOMAIN REVEALS A CONVERGENT RECOGNITION SCAFFOLD MEDIATING INHIBITION OF MYELINATION |
1P8T | A:202-261; A:202-261; A:202-261 | CRYSTAL STRUCTURE OF NOGO-66 RECEPTOR |
2V70 | D:606-666; D:606-666; D:606-666; D:606-666 | THIRD LRR DOMAIN OF HUMAN SLIT2 |
2V9S | D:324-384; D:324-384; D:324-384; D:324-384; D:324-384; D:324-384; D:324-384; D:324-384 | SECOND LRR DOMAIN OF HUMAN SLIT2 |
2V9T | B:324-384; B:324-384 | COMPLEX BETWEEN THE SECOND LRR DOMAIN OF SLIT2 AND THE FIRST IG DOMAIN FROM ROBO1 |
2WFH | B:801-861; B:801-861; B:801-861; B:801-861 | THE HUMAN SLIT 2 DIMERIZATION DOMAIN D4 |
2Z7X | B:445-476; B:445-476; B:445-476; A:387-448; A:387-448; A:387-448 | CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE |
2Z80 | B:101-160; B:101-160; B:101-160; B:101-160 | CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE |
2Z62 | A:78-138; A:78-138 | CRYSTAL STRUCTURE OF THE TV3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61 |
2Z63 | A:496-527; A:496-527; A:496-527; A:496-527; A:496-527; A:496-527; A:496-527 | CRYSTAL STRUCTURE OF THE TV8 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61 |
2Z65 | B:78-138; B:78-138; B:78-138; B:78-138 | CRYSTAL STRUCTURE OF THE HUMAN TLR4 TV3 HYBRID-MD-2-ERITORAN COMPLEX |
2Z66 | D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556; D:496-556 | CRYSTAL STRUCTURE OF THE VT3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61 |
2XWT | C:52-114 | CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY |